Search research articles
Contact Us
Filters
Showing results (1-10 of 105) with videos related to
Page
of 11
Sort By:
Current Molecular Medicine
|
September 11, 2004
Progress in vaccine research and possible effector mechanisms in visceral leishmaniasis
Rajesh Ravindran, Nahid Ali
Plos Neglected Tropical Diseases
|
August 22, 2014
Combining cationic liposomal delivery with MPL-TDM for cysteine protease cocktail vaccination against Leishmania donovani: evidence for antigen synergy and protection
Amrita Das, Nahid Ali
Expert Review of Vaccines
|
August 24, 2012
Vaccine prospects of killed but metabolically active Leishmania against visceral leishmaniasis
Amrita Das, Nahid Ali
Expert Opinion on Drug Delivery
|
July 2, 2008
Recent developments in leishmaniasis vaccine delivery systems
Sudipta Bhowmick, Nahid Ali
Antimicrobial Agents and Chemotherapy
|
October 24, 2007
Oral Therapy with Amlodipine and Lacidipine, 1,4-Dihydropyridine Derivatives Showing Activity against Experimental Visceral Leishmaniasis
Partha Palit, Nahid Ali
Plos Neglected Tropical Diseases
|
October 21, 2015
Correction: Combining Cationic Liposomal Delivery with MPL-TDM for Cysteine Protease Cocktail Vaccination against Leishmania donovani: Evidence for Antigen Synergy and Protection
Amrita Das, Nahid Ali
Molecular Biology International
|
November 18, 2011
Evasion of Host Defence by Leishmania donovani: Subversion of Signaling Pathways
Md Shadab, Nahid Ali
Plos One
|
June 9, 2009
Identification of novel Leishmania donovani antigens that help define correlates of vaccine-mediated protection in visceral leishmaniasis
Sudipta Bhowmick, Nahid Ali
Expert Review of Vaccines
|
September 22, 2021
Nanovaccine: an emerging strategy
Amrita Das, Nahid Ali
Immunotherapy
|
October 4, 2013
Translating immune cell cross-talk into a treatment opportunity for visceral leishmaniasis
Nahid Ali, Pradyot Bhattacharya
Page
of 11
Search research articles
Search
Showing results (1-10 of 105) with videos related to
Sort By:
Page
of 11
Current Molecular Medicine
|
September 11, 2004
Progress in vaccine research and possible effector mechanisms in visceral leishmaniasis
Rajesh Ravindran, Nahid Ali
Plos Neglected Tropical Diseases
|
August 22, 2014
Combining cationic liposomal delivery with MPL-TDM for cysteine protease cocktail vaccination against Leishmania donovani: evidence for antigen synergy and protection
Amrita Das, Nahid Ali
Expert Review of Vaccines
|
August 24, 2012
Vaccine prospects of killed but metabolically active Leishmania against visceral leishmaniasis
Amrita Das, Nahid Ali
Expert Opinion on Drug Delivery
|
July 2, 2008
Recent developments in leishmaniasis vaccine delivery systems
Sudipta Bhowmick, Nahid Ali
Antimicrobial Agents and Chemotherapy
|
October 24, 2007
Oral Therapy with Amlodipine and Lacidipine, 1,4-Dihydropyridine Derivatives Showing Activity against Experimental Visceral Leishmaniasis
Partha Palit, Nahid Ali
Plos Neglected Tropical Diseases
|
October 21, 2015
Correction: Combining Cationic Liposomal Delivery with MPL-TDM for Cysteine Protease Cocktail Vaccination against Leishmania donovani: Evidence for Antigen Synergy and Protection
Amrita Das, Nahid Ali
Molecular Biology International
|
November 18, 2011
Evasion of Host Defence by Leishmania donovani: Subversion of Signaling Pathways
Md Shadab, Nahid Ali
Plos One
|
June 9, 2009
Identification of novel Leishmania donovani antigens that help define correlates of vaccine-mediated protection in visceral leishmaniasis
Sudipta Bhowmick, Nahid Ali
Expert Review of Vaccines
|
September 22, 2021
Nanovaccine: an emerging strategy
Amrita Das, Nahid Ali
Immunotherapy
|
October 4, 2013
Translating immune cell cross-talk into a treatment opportunity for visceral leishmaniasis
Nahid Ali, Pradyot Bhattacharya
Page
of 11